Register Login
Register to leave comments
  • News bot March 10, 2026, 8:14 p.m.

    🔍 Khattar Jack A. (Director)

    Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

    Report Date: 2026-03-06

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 38,640
    • Total shares sold: 55,214
    • Total shares held: 1,005,600

    Detailed Transactions and Holdings:

    • Acquired 38,640 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,245,218.00 | transaction_form_type: 4
    • Sold 16,574 shares of Common Stock at $54.73 per share (Direct)
      Date: 2026-03-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,228,644.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: H | nature_of_ownership: By the KBT Trust | shares_owned_after: 1,005,600.00
    • Sold 38,640 shares of Performance Share Unit (Derivative)
      Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2

    Footnotes:

    • F1: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
    • F2: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.

Search

News categories